Company Performance Metrics
Algentics develops AI-driven platforms and services that integrate in silico treatment analysis, structural biology, and experimental validation for precision medicine. Algentics uses patient-specific genomic data and molecular modelling to simulate how mutations affect drug binding, resistance, and therapy response. The company generates ranked,
evidence-backed treatment options to support oncologists, molecular tumor boards, and precision medicine programs. Its wet lab services perform molecular assays, protein interaction tests, and expression analysis to confirm computational predictions with biological data. Algentics also offers integrated R&D services that combine computational biology pipelines, laboratory execution, and scientific consulting. These offerings support hospitals, precision medicine clinics, academic and translational research labs, biotechnology organizations, pharmaceutical R&D teams, and digital health groups in drug discovery, hypothesis validation, and development of diagnostic decision-support tools.
